ERBB2 and breast carcinoma: In summary, this study aims to identify ultrasound and clinicopathological characteristics related to the recurrence of HER2+ breast cancer, and construct HR−/HER2+ and HR+/HER2− nomograms, respectively, to assist with clinical prediction of disease recurrence.